Form 4 for RNXT RenovoRx, Inc.
Accepted 2025-12-17 00:00:00 ET · period of report 2025-12-16 · accession 0001493152-25-028057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-17 | 2025-12-16 | RNXT | Agah Ramtin | Chief Medical Off, Dir | P - Purchase | $0.85 | +12.0K | 778.5K | +2% | +$10.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-16 | P | A | 12,000 | $0.85 | 778,460 | D | — | — | (F1) Reflects an open market purchase of the Issuer's securities. |